This study is currently not recruiting participants.

The evaluation of the necessity of using heparin in an UltraTag RBC kit when tagging blood for a nuclear medicine study.

Investigating the Need for Heparin in Blood Tagging for Imaging

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to see if we really need heparin in the syringe prior to tagging the blood to our medicine.

Detailed description of study

The purpose of this study is to see if we really need heparin in the syringe prior to tagging the blood to our radioactive medicine in nuclear medicine for imaging.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: healthy
  • Age: 18 years - 100 years
  • Gender: All

The purpose of this study is to investigate if using heparin in a syringe is necessary when tagging blood with a radioactive substance. This process is used in nuclear medicine for imaging, which helps doctors see inside the body using special pictures.

Participants in this study will undergo procedures involving the tagging of blood with a radioactive substance. This involves using a syringe, and the study will determine if adding heparin, a substance that prevents blood clots, is required during this process.

  • Who can participate: Individuals aged 18 and older, who are undergoing nuclear medicine procedures and meet specific health criteria, may be eligible to participate.
  • Study details: Participants will have their blood tagged with a radioactive substance using a syringe. The study will evaluate the necessity of heparin, a blood thinner, in this process.
Updated on 19 Feb 2024. Study ID: 1506958805

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team